Literature DB >> 17564403

Sedating medications and undiagnosed obstructive sleep apnea: physician determinants and patient consequences.

Brandon Lu1, Rohit Budhiraja, Sairam Parthasarathy.   

Abstract

BACKGROUND: Sedative medications may be inadvertently prescribed to patients with undiagnosed obstructive sleep apnea (OSA) and may worsen daytime sleepiness. STUDY
OBJECTIVES: To determine whether patients with undiagnosed OSA were prescribed sedative medications and whether such prescriptions increased the risk for traffic accidents. A secondary objective was to determine physician characteristics associated with such prescription practices.
DESIGN: Retrospective chart review. Telephone interviews of patients and physicians. INTERVENTION: None. PATIENTS: One hundred fifty-one consecutive patients at a sleep laboratory.
RESULTS: Forty-one of 137 (30%) patients with undiagnosed OSA had received prescriptions for sedating medications. Regression analysis identified self-report of sleepiness while driving (p = .05) and prescription for risperidone as independent risk factors for motor vehicle accidents (p = .005), while prescription of any sedative (excluding risperidone) tended to be associated with accidents (p =.10). In patients with severe OSA, prescription of sedating medications was associated with a greater risk for motor vehicle accidents than those without such prescriptions (relative risk = 2.6; p = .04). In patients with prescription for sedating medications (n = 41), the apnea-hypopnea index was directly proportional to the risk for motor vehicle accidents (r2 = 0.26; p = .001) suggesting a 'dose effect' of severity of sleep-disordered breathing on risk for accidents. Physicians who did not usually treat patients with sleep disorders were more likely to prescribe sedatives to patients with undiagnosed OSA than were physicians with such expertise: neurologist, pulmonologist, or psychiatrist (52% vs 10%; relative risk = 5.2; p = .02)
CONCLUSION: Prescription of sedating medications may increase the risk of road accidents in patients with undiagnosed severe OSA, and such prescription practices are less likely to occur in physicians with expertise in sleep medicine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17564403

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  18 in total

Review 1.  Physiology in medicine: obstructive sleep apnea pathogenesis and treatment--considerations beyond airway anatomy.

Authors:  Jerome A Dempsey; Ailiang Xie; David S Patz; David Wang
Journal:  J Appl Physiol (1985)       Date:  2013-11-07

2.  The need for pharmacovigilance in sleep medicine.

Authors:  Sairam Parthasarathy
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

3.  Factors associated with referrals for obstructive sleep apnea evaluation among community physicians.

Authors:  Natasha J Williams; João V Nunes; Ferdinand Zizi; Kola Okuyemi; Collins O Airhihenbuwa; Gbenga Ogedegbe; Girardin Jean-Louis
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

4.  Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data.

Authors:  Nicholas T Vozoris; Richard S Leung
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

5.  A multicenter prospective comparative effectiveness study of the effect of physician certification and center accreditation on patient-centered outcomes in obstructive sleep apnea.

Authors:  Sairam Parthasarathy; Shyam Subramanian; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2014-03-15       Impact factor: 4.062

6.  Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold.

Authors:  Danny J Eckert; Robert L Owens; Geoffrey B Kehlmann; Andrew Wellman; Shilpa Rahangdale; Susie Yim-Yeh; David P White; Atul Malhotra
Journal:  Clin Sci (Lond)       Date:  2011-06       Impact factor: 6.124

7.  Eszopiclone and dexmedetomidine depress ventilation in obese rats with features of metabolic syndrome.

Authors:  William A Filbey; David T Sanford; Helen A Baghdoyan; Lauren G Koch; Steven L Britton; Ralph Lydic
Journal:  Sleep       Date:  2014-05-01       Impact factor: 5.849

Review 8.  Are opioids associated with sleep apnea? A review of the evidence.

Authors:  James M Walker; Robert J Farney
Journal:  Curr Pain Headache Rep       Date:  2009-04

9.  Frequency and predictors of obstructive sleep apnea among individuals with major depressive disorder and insomnia.

Authors:  Jason C Ong; Jenna L Gress; Melanie G San Pedro-Salcedo; Rachel Manber
Journal:  J Psychosom Res       Date:  2009-04-25       Impact factor: 3.006

Review 10.  Evidence-based recommendations for the assessment and management of sleep disorders in older persons.

Authors:  Harrison G Bloom; Imran Ahmed; Cathy A Alessi; Sonia Ancoli-Israel; Daniel J Buysse; Meir H Kryger; Barbara A Phillips; Michael J Thorpy; Michael V Vitiello; Phyllis C Zee
Journal:  J Am Geriatr Soc       Date:  2009-05       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.